U.S. Preventive Medicine Announces Investment Banking Team

U.S. Preventive Medicine®, recently announced the selection of its investment banking team, composed of Credit Suisse, Deutsche Bank, Merrill Lynch, UBS and Stanford Eagle to coordinate its long term capital strategy, mergers and acquisition efforts in the U.S. and internationally.

“The selection of some of the nation’s best investment banks to co-manage our long term capitalization and M&A strategy is significant as we continue to align this company with the 'best of the best' in the global financial markets. As the first entity in the U.S. and internationally to offer a full continuum of geographically dispersed, comprehensive solutions for personalized medicine including preventive care, wellness and disease management, the addition of these leading financial advisors is very important,” said Christopher T. Fey, Chairman and CEO of U.S. Preventive Medicine. “This is just one more sequential step in our planned growth of the business.”